Generic Name and Formulations:
Gatifloxacin 0.5%; oph soln; contains benzalkonium chloride.
Indications for ZYMAXID:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not established. ≥1yr: 1 drop every 2hrs in affected eye(s) while awake (max 8 doses) on day 1, then 1 drop in affected eye(s) 2–4 times daily while awake on days 2–7.
Discontinue if superinfection or hypersensitivity occurs. Corneal endothelial cell injury. Pregnancy. Nursing mothers.
Worsening conjunctivitis, irritation, dysgeusia, eye pain/discharge.
Neurology Advisor Articles
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- New 15-Item Dyspnea-ALS-Score Assesses Dyspnea in ALS
- CDC: About One in Five U.S. Adults Have Chronic Pain
- Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
- Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies